In recent years, it was proven that semi-automated insulin administration in the case of T1DM is able to provide satisfactory glycemia levels over the years, and it is able to reduce the risk of developing serious side effects [7,8]. The gene discussed is INS; the disease is type 1 diabetes mellitus.